NEPHROCARE HEALTH SERV L Financial Ratios
NEPHROPLUS · Healthcare · Current price ₹692.2
P/E ratio
90.4x
P/B ratio
6.1x
ROE
9.1%
ROCE
15.0%
Debt / Equity
0.01
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 90.4x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 6.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 9.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 15.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.01 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with NEPHROCARE HEALTH SERV L's latest numbers.
NEPHROCARE HEALTH SERV L profitability
NEPHROCARE HEALTH SERV L generates a return on equity of 9.1% and a return on capital employed of 15.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.01 and a P/E of 90.4x, NEPHROCARE HEALTH SERV L is conservatively financed. Our overall business-quality score for the company is 5.3 / 10.
Understand the ratios
More on NEPHROCARE HEALTH SERV L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.